The scientific focus adapted
to express the optimum potential
of your molecule

Marketing:
Unparalleled vision in metabolic disorders and risk assessment expertise for post-marketing studies and drug repositioning.

HeartArteryMacrophageLiverMusclePancreasAdipose Tissue

Preclinical development:
In-house predictive models and tracer technologies enable the generation of Proof of Concept efficacy data for your drugs.

Discovery:
Screening and lead validation utilize a dedicated research platform which combine with our focused scientific vision.

Home > Events > Physiogenex to present its 3-week NASH screening mouse model and the Diet-Induced NASH hamster model at the APASL 2017 in Shanghai.

Events detail

Return to all news & events

02/07/2017 Physiogenex to present its 3-week NASH screening mouse model and the Diet-Induced NASH hamster model at the APASL 2017 in Shanghai.

Physiogenex will present its 3-week NASH screening model and the Diet-Induced NASH (DIN) hamster model during the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL), February 15-19, 2017 in Shanghai, China.

These models will be presented by Dr. François Briand, Director of Research and Business Development at Physiogenex, during oral abstracts and poster sessions on Saturday February the 18th, 2017.

If you want to set an appointment during the APASL 2017 with Dr. François Briand and/or discuss about our NASH models, please contact us!